Get started
Author

M. Marcq

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study
2016 · Romain Corre, Laurent Greillier, et al. · Journal of Clinical Oncology · 407
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study
2019 · Alice Tison, Gilles Quéré, et al. · Arthritis & Rheumatology · 321
PDF
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study
2024 · Luis G. Paz-Ares, Oscar Juan-Vidal, et al. · Journal of Clinical Oncology · 155
PDF
Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients
2013 · Audrey Vallée, Marie Marcq, et al. · Lung Cancer · 85
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study
2017 · H. Bourgeois, F. Grudé, et al. · Annals of Oncology · 54
Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors
2018 · Karima Saboundji, Jean-Bernard Auliac, et al. · Targeted Oncology · 42
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)
2022 · Renaud Descourt, Laurent Greillier, et al. · Cancer Immunology Immunotherapy · 30
Cytotoxic T Cell Responses against Mesothelioma by Apoptotic Cell-pulsed Dendritic Cells
2004 · Frédéric Ebstein, Carole Sapede, et al. · American Journal of Respiratory and Critical Care Medicine · 28
Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial
2019 · Jaafar Bennouna, Nicolas Girard, et al. · Clinical Lung Cancer · 24
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study
2024 · Hervé Léna, Laurent Greillier, et al. · The Lancet Respiratory Medicine · 23
PDF
Detection of EGFR Mutations in the Plasma of Patients with Lung Adenocarcinoma for Real-Time Monitoring of Therapeutic Response to Tyrosine Kinase Inhibitors?
2014 · Marie Marcq, Audrey Vallée, et al. · Journal of Thoracic Oncology · 22
Pleurésies malignes révélatrices d’un cancer : comparaison des étiologies avec les pleurésies métastatiques d’un cancer connu
2008 · L. Cellerin, M. Marcq, et al. · Revue des Maladies Respiratoires · 13
OP0196 Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune diseases: a nationwide multicenter retrospective study
2018 · A. Tison, G. Quere, et al. · Annals of the Rheumatic Diseases · 12
PDF
Aspergilloses respiratoires complexes : difficultés diagnostiques et thérapeutiques
2004 · M. Marcq, P. Germaud, et al. · Revue des Maladies Respiratoires · 9
Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study
2023 · Pierre-Louis Declercq, Isabelle Fournel, et al. · Intensive Care Medicine · 8
PDF
Une maladie de Carrington sans éosinophilie au lavage broncho-alvéolaire
2007 · M. Marcq, A. De Muret, et al. · Revue des Maladies Respiratoires · 8
Three-Year Overall Survival of Patients With Advanced Non–Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study)
2023 · Chantal Decroisette, Laurent Greillier, et al. · Journal of Immunotherapy · 7
L’hémorragie intra-alvéolaire, une complication rare du syndrome primaire des antiphospholipides
2008 · M. Lafosse-Marin, M. Marcq, et al. · La Revue de Médecine Interne · 7
Difficultés de la prise en charge d’une forme pulmonaire isolée du syndrome de Goodpasture
2008 · J. Buret, M. Marcq, et al. · Revue des Maladies Respiratoires · 5
13P: Brain metastases and actionable genetic alterations with sacituzumab govitecan versus docetaxel in metastatic non-small cell lung cancer: Subgroups of the phase III EVOKE-01 trial
2025 · E. Felip, P. Garrido Lopez, et al. · Journal of Thoracic Oncology · 2
PDF
First-line pembrolizumab monotherapy for PD-L1-positive (TPS ≥ 50%) advanced non-small cell lung cancer (aNSCLC) in the real world: A national French bispective multicentric cohort—ESCKEYP trial (GFPC 05-2018).
2021 · Renaud Descourt, Laurent Greillier, et al. · Journal of Clinical Oncology · 2
Absolute Quantification of Nucleotide Variants in Cell-Free DNA via Quantitative NGS: Clinical Application in Non-Small Cell Lung Cancer Patients
2025 · Guillaume Herbreteau, Marie Marcq, et al. · Cancers · 1
A Comparative Multicenter Cohort Study Evaluating the Long-Term Influence of the Strict Lockdown during the First COVID-19 Wave on Lung Cancer Patients (ARTEMISIA Trial)
2023 · Olivier Molinier, Camille Guguen, et al. · Cancers · 1
PDF
1359P Relationship between tumor TP53 gene mutation, circulating anti-p53 antibodies and response to first-line osimertinib in EGFR-mutated NSCLC patients
2023 · M.G. Denis, G. Herbreteau, et al. · Annals of Oncology · 1
PDF
Explore ALK: Alectinib activity in patients with ALK+ metastatic non-small cell lung cancer—A national real world analysis (GFPC 03-2019).
2023 · Aurélie Swalduz, Gaelle Rousseau-Bussac, et al. · Journal of Clinical Oncology · 1
Works count: 57
Citation count: 1,270
H-index: 12
I10-index: 13
Year
Topic
Type